Adkisson Joins NellOne Scientific Advisory Board
NellOne Therapeutics, Inc. (NellOne), a virtually integrated biopharmaceutical company commercializing a proprietary recombinant protein for treating inflammatory respiratory diseases, is pleased to announce that Wren S Adkisson, MSN, has joined its Scientific Advisory Board.
Culiat Recognized Among Most Influential Filipina Women in the World
NellOne Therapeutics Inc. (NellOne) Chief Science Officer, Dr. Cymbeline (Bem) Culiat, to receive the prestigious “Most Influential Filipina Woman in the World” award from the Foundation for Filipina Women’s Network.
Local Company Strives to Fill Gap in Treating COVID-19 Sufferers
Dr. Cymbeline Culiat recently shared with Friends of ORNL how NellOne is pursuing a fast-track path toward obtaining approval of a new drug for human clinical trials through the FDA’s Coronavirus Treatment Acceleration Program.
Scientist-entrepreneur to talk about regenerative medicine, potential COVID treatment
NellOne Therapeutics Inc. (NellOne) Chief Science Officer, Dr. Cymbeline (Bem) Culiat, to discuss regenerative medicine at virtual lecture for Friends of ORNL.
NellOne CEO Receives Impact Award
[Knoxville, TN] October 2021- Bill Malkes, Chief Executive Officer of NellOne Therapeutics, is the recipient of the 2021 Innov865 Impact Award. The Innov865 Impact Award, presented by Verizon, celebrates innovation and entrepreneurship in the community by recognizing...
Could Your Body Lend Clues to Healing Relationships?
WVLT's Anne Brock recently sat down with NellOne Co-Founder and Chief Science Officer, Dr. Cymbeline "Bem" Culiat, on her research into healing after COVID-19 and her recently launched book, Designed to Heal, co-authored with physician and theologian Jennie McLaurin....
490 BioTech and NellOne Expanding Partnership to Fight ARDS
[Knoxville, TN], August 9, 2021 – 490 BioTech and NellOne Therapeutics, Inc., two leaders in Tennessee’s thriving entrepreneurial community and members of its growing biotechnology cluster, announced today they are expanding their partnership to fight against acute...
NellOne CSO Co-Authors Book on the Bodies’ Innate Tissue Healing Responses
Dr. Cymbeline T. (Bem) Culiat, Co-Founder and Chief Science Officer for NellOne Therapeutics, Inc. (NellOne), along with pediatrician, and public health expert, Dr. Jennie A. McLaurin, co-authored a groundbreaking book,
NellOne Awarded Competitive Grant from the National Science Foundation
Small Business Innovation Research Program Provides Seed Funding for R&D [Knoxville, TN], April 26, 2021 – NellOne Therapeutics, Inc. (NellOne) has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) Phase I grant for...
NellOne Therapeutics utilizes ORNL’s “COVID-19 Rapid Access Licensing Program”
The novel coronavirus is no doubt top of mind for most people with the infection numbers rising rapidly on a daily, so an announcement last week from Oak Ridge National Laboratory (ORNL) that involves a local early stage biopharmaceutical...
NellOne Therapeutics partners with ORNL on COVID-19 drug delivery system
NellOne Therapeutics of Knoxville, Tenn., has licensed a drug delivery system from the Department of Energy’s Oak Ridge National Laboratory that is designed to transport therapeutics directly to cells infected by SARS-CoV-2, the virus causing COVID-19. The technology...
Anti-inflammatory molecules that treat cystic fibrosis may fight COVID-19
By Sarah Marshall, Uniformed Services University of the Health Sciences WASHINGTON -- Efforts are underway at the Uniformed Services University of the Health Sciences to support the fight against the pandemic, including some that apply existing research and knowledge...